These findings are consistent with those reported in previous studies showing that women have greater amounts of global AD pathology, especially greater numbers of NFTs than men.14,36,37 Moreover, our results support the immunohistochemical study of the nbM that has shown greater tau immunoreactivity in women than in men.35 This evidence concerns the gene MAPT and Alzheimer disease.